Major corporations Walmart and Eli Lilly join regulatory opposition to OKX and ICE's tokenized stock platform plans.
Regulation & Gov ·
Walmart and Eli Lilly have joined a growing roster of corporations opposing the tokenized stock trading platform jointly developed by cryptocurrency exchange OKX and ICE. The two companies have moved to block their shares from trading on the venue, adding to regulatory resistance against the initiative. Combined with objections from Cigna, Carnival, and Arcos Dorados, the total number of companies blocking participation has reached 38.
The tokenized stock platform represents an effort to enable fractional ownership and blockchain-based settlement of equities. OKX and ICE designed the venue to operate within regulatory frameworks, yet the mounting corporate opposition signals concerns among major enterprises about participation in the offering. The nature of those concerns—whether stemming from legal uncertainty, reputational risk, operational complexity, or other factors—has not been detailed.
The scale of corporate refusal remains an open question for the platform's viability. Whether additional companies will join the objections, how regulators will ultimately treat the venue, and what operational adjustments OKX and ICE may pursue remain unresolved.